Organotypic brain slices: A model to study the neurovascular unit micro-environment in epilepsies

Fluids and Barriers of the CNS

Volumn 10, Issue 1, 2013, Pages

  Morin Brureau, Mélanie ^a,b   De Bock, Frédéric ^a   Lerner Natoli, Mireille ^a  

^a INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Blood brain barrier (BBB); Epilepsy; Neurovascular unit (NVU); Organotypic brain slices

Indexed keywords

TIGHT JUNCTION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; BRAIN SLICE; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; TEMPORAL LOBE EPILEPSY;

EID: 84875353019     PISSN: None     EISSN: 20458118     Source Type: Journal    
DOI: 10.1186/2045-8118-10-11     Document Type: Article

References (77)

1. Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006, 7:41-53. 10.1038/nrn1824, 16371949.
2. Bennett J, Basivireddy J, Kollar A, Biron KE, Reickmann P, Jefferies WA, McQuaid S. Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE. J Neuroimmunol 2010, 229:180-191. 10.1016/j.jneuroim.2010.08.011, 20832870.
3. Friedman A. Blood-brain barrier dysfunction, status epilepticus, seizures, and epilepsy: a puzzle of a chicken and egg?. Epilepsia 2011, 52(Suppl 8):19-20. 3234990, 21967353.
4. Tomkins O, Feintuch A, Benifla M, Cohen A, Friedman A, Shelef I. Blood-brain barrier breakdown following traumatic brain injury: a possible role in posttraumatic epilepsy. Cardiovasc Psychatry Neurol 2011, 2011:765923.
5. Ujiie M, Dickstein DL, Carlow DA, Jefferies WA. Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation 2003, 10:463-470.
6. Naik P, Cucullo L. In vitro blood-brain barrier models: current and perspective technologies. J Pharm Sci 2012, 101:1337-1354. 10.1002/jps.23022, 22213383.
7. Wilhelm I, Fazakas C, Krizbai IA. In vitro models of the blood-brain barrier. Acta neurobiolExp (Wars) 2011, 71:113-128.
8. Silbergeld DL, Ali-Osman F. Isolation and characterization of microvessels from normal brain and brain tumors. J Neurooncol 1991, 11:49-55. 10.1007/BF00166997, 1919646.
9. Hamm S, Dehouck B, Kraus J, Wolburg-Buchholz K, Wolburg H, Risau W, Cecchelli R, Engelhardt B, Dehouck MP. Astrocyte mediated modulation of blood-brain barrier permeability does not correlate with a loss of tight junction proteins from the cellular contacts. Cell Tissue Res 2004, 315:157-166. 10.1007/s00441-003-0825-y, 14615934.
10. Hori S, Ohtsuki S, Tachikawa M, Kimura N, Kondo T, Watanabe M, Nakashima E, Terasaki T. Functional expression of rat ABCG2 on the luminal side of brain capillaries and its enhancement by astrocyte-derived soluble factor(s). J Neurochem 2004, 90:526-536. 10.1111/j.1471-4159.2004.02537.x, 15255930.
11. Dore-Duffy P, Cleary K. Morphology and properties of pericytes. Methods Mol Biol 2011, 686:49-68. 10.1007/978-1-60761-938-3_2, 21082366.
12. Al Ahmad A, Taboada CB, Gassmann M, Ogunshola OO. Astrocytes and pericytes differentially modulate blood-brain barrier characteristics during development and hypoxic insult. J Cereb Blood Flow 2011, 31:693-705.
13. Cucullo L, Marchi N, Hossain M, Janigro D. A dynamic in vitro BBB model for the study of immune cell trafficking into the central nervous system. J Cereb Blood Flow 2011, 31:767-777.
14. Hallier-Vanuxeem D, Prieto P, Culot M, Diallo H, Landry C, Tahti H, Cecchelli R. New strategy for alerting central nervous system toxicity: Integration of blood-brain barrier toxicity and permeability in neurotoxicity assessment. Toxicol in vitro 2009, 23:447-453. 10.1016/j.tiv.2008.12.011, 19135142.
15. Hatherell K, Couraud PO, Romero IA, Weksler B, Pilkington GJ. Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models. J Neurosci Methods 2011, 199:223-229. 10.1016/j.jneumeth.2011.05.012, 21609734.
16. Gahwiler BH. Organotypic monolayer cultures of nervous tissue. J Neurosci Methods 1981, 4:329-342. 10.1016/0165-0270(81)90003-0, 7033675.
17. Stoppini L, Buchs PA, Muller D. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 1991, 37:173-182. 10.1016/0165-0270(91)90128-M, 1715499.
18. Del Turco D, Deller T. Organotypic entorhino-hippocampal slice cultures-a tool to study the molecular and cellular regulation of axonal regeneration and collateral sprouting in vitro. Methods Mol Biol 2007, 399:55-66. 10.1007/978-1-59745-504-6_5, 18309925.
19. Gahwiler BH, Capogna M, Debanne D, McKinney RA, Thompson SM. Organotypic slice cultures: a technique has come of age. Trends Neurosci 1997, 20:471-477. 10.1016/S0166-2236(97)01122-3, 9347615.
20. Moser KV, Humpel C. Vascular endothelial growth factor counteracts NMDA-induced cell death of adult cholinergic neurons in rat basal nucleus of Meynert. Brain Res Bull 2005, 65:125-131. 10.1016/j.brainresbull.2004.12.005, 15763178.
21. Morin-Brureau M, Lebrun A, Rousset MC, Fagni L, Bockaert J, de Bock F, Lerner-Natoli M. Epileptiform activity induces vascular remodeling and ZO-1 downregulation in organotypic hippocampal cultures: role of VEGF signaling pathways. J Neurosci 2011, 31:10677-10688. 10.1523/JNEUROSCI.5692-10.2011, 21775611.
22. Rigau V, Morin M, Rousset MC, de Bock F, Lebrun A, Coubes P, Picot MC, Baldy-Moulinier M, Bockaert J, Crespel A, Lerner-Natoli M. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain 2007, 130:1942-1956. 10.1093/brain/awm118, 17533168.
23. de Paz P, Barrio JP. Stereological parameters from the analysis of the cell micrographs either by manual point-counting methods or by using a semi-automatic system: a BASIC program for ZX-Spectrum personal computer. Comput Biol Med 1985, 15:153-158. 10.1016/0010-4825(85)90028-9, 3891214.
24. Horowitz A, Simons M. Branching morphogenesis. Cir Res 2008, 103:784-795.
25. Poulsen FR, Jahnsen H, Blaabjerg M, Zimmer J. Pilocarpine-induced seizure-like activity with increased BNDF and neuropeptide Y expression in organotypic hippocampal slice cultures. Brain Res 2002, 950:103-118. 10.1016/S0006-8993(02)03009-3, 12231234.
26. Ziobro JM, Deshpande LS, Delorenzo RJ. An organotypic hippocampal slice culture model of excitotoxic injury induced spontaneous recurrent epileptiform discharges. Brain Res 2011, 1371:110-120. 3022076, 21111720.
27. de Bock F, Derijard B, Dornand J, Bockaert J, Rondouin G. The neuronal death induced by endotoxic shock but not that induced by excitatory amino acids requires TNF-alpha. Eur J Neurosci 1998, 10:3107-3114. 10.1046/j.1460-9568.1998.00317.x, 9786205.
28. Abbott NJ. Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 2002, 200:629-638. 10.1046/j.1469-7580.2002.00064.x, 1570746, 12162730.
29. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis 2010, 37:13-25. 10.1016/j.nbd.2009.07.030, 19664713.
30. Wolburg H, Noell S, Mack A, Wolburg-Buchholz K, Fallier-Becker P. Brain endothelial cells and the glio-vascular complex. Cell Tissue Res 2009, 335:75-96. 10.1007/s00441-008-0658-9, 18633647.
31. Correale J, Villa A. Cellular elements of the blood-brain barrier. Neurochem Res 2009, 34:2067-2077. 10.1007/s11064-009-0081-y, 19856206.
32. Bendfeldt K, Radojevic V, Kapfhammer J, Nitsch C. Basic fibroblast growth factor modulates density of blood vessels and preserves tight junctions in organotypic cortical cultures of mice: a new in vitro model of the blood-brain barrier. J Neurosci 2007, 27:3260-3267. 10.1523/JNEUROSCI.4033-06.2007, 17376986.
33. Jarvela JT, Ruohonen S, Kukko-Lukjanov TK, Plysjuk A, Lopez-Picon FR, Holopainen IE. Kainic acid-induced neurodegeneration and activation of inflammatory processes in organotypic hippocampal slice cultures: treatment with cyclooxygenase-2 inhibitor does not prevent neuronal death. Neuropharmacology 2011, 60:1116-1125. 10.1016/j.neuropharm.2010.09.024, 20932983.
34. Barichello T, Generoso JS, Silvestre C, Costa CS, Carrodore MM, Cipriano AL, Michelon CM, Petronilho F, Dal-Pizzol F, Vilela MC, Teixeira AL. Circulating concentrations, cerebral output of the CINC-1 and blood-brain barrier disruption in Wistar rats after pneumococcal meningitis induction. Eur J Clin Microbiol Infect Dis 2012, 31:2005-2009. 10.1007/s10096-011-1533-2, 22302624.
35. Keeley EC, Mehrad B, Strieter RM. Chemokines as mediators of tumor angiogenesis and neovascularization. Exp Cell Res 2011, 317:685-690. 10.1016/j.yexcr.2010.10.020, 3073599, 21040721.
36. Ahuja SK, Murphy PM. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 1996, 271:20545-20550. 10.1074/jbc.271.34.20545, 8702798.
37. Wolpe SD, Sherry B, Juers D, Davatelis G, Yurt RW, Cerami A. Identification and characterization of macrophage inflammatory protein 2. Proc Natl Acad Sci U S A 1989, 86:612-616. 10.1073/pnas.86.2.612, 286522, 2643119.
38. Linker R, Gold R, Luhder F. Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination. Crit Rev Immunol 2009, 29:43-68. 10.1615/CritRevImmunol.v29.i1.20, 19348610.
39. Bernardini G, Ribatti D, Spinetti G, Morbidelli L, Ziche M, Santoni A, Capogrossi MC, Napolitano M. Analysis of the role of chemokines in angiogenesis. J Immunol Methods 2003, 273:83-101. 10.1016/S0022-1759(02)00420-9, 12535800.
40. Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo JA, Vath J, Gosselin M, Ma J, Dussault B. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 1997, 387:611-617. 10.1038/42491, 9177350.
41. Niu X, Wang H, Fu ZF. Role of chemokines in rabies pathogenesis and protection. Adv Virus Res 2011, 79:73-89.
42. Iwami K, Natsume A, Wakabayashi T. Cytokine networks in glioma. Neurosurg Rev 2011, 34:253-263. discussion 263-254, 10.1007/s10143-011-0320-y, 21656131.
43. Naldini A, Carraro F. Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy 2005, 4:3-8. 10.2174/1568010053622830, 15720228.
44. Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 2007, 96:41-101.
45. Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 1992, 263:C1-16.
46. Gloor SM, Weber A, Adachi N, Frei K. Interleukin-1 modulates protein tyrosine phosphatase activity and permeability of brain endothelial cells. Biochem Biophys Res Commun 1997, 239:804-809. 10.1006/bbrc.1997.7557, 9367850.
47. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y, Dinarello CA, Apte RN. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci U S A 2003, 100:2645-2650. 10.1073/pnas.0437939100, 151394, 12598651.
48. de Vries HE, Blom-Roosemalen MC, van Oosten M, de Boer AG, van Berkel TJ, Breimer DD, Kuiper J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol 1996, 64:37-43. 10.1016/0165-5728(95)00148-4, 8598388.
49. Bar D, Apte RN, Voronov E, Dinarello CA, Cohen S. A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development. FASEB J 2004, 18:161-163.
50. Banks WA, Erickson MA. The blood-brain barrier and immune function and dysfunction. Neurobiol Dis 2010, 37:26-32. 10.1016/j.nbd.2009.07.031, 19664708.
51. Bae J, Park D, Lee YS, Jeoung D. Interleukin-2 promotes angiogenesis by activation of Akt and increase of ROS. J Microbiol Biotechnol 2008, 18:377-382.
52. Dentelli P, Del Sorbo L, Rosso A, Molinar A, Garbarino G, Camussi G, Pegoraro L, Brizzi MF. Human IL-3 stimulates endothelial cell motility and promotes in vivo new vessel formation. J Immunol 1999, 163:2151-2159.
53. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 2011, 1813:878-888. 10.1016/j.bbamcr.2011.01.034, 21296109.
54. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004, 22:929-979. 10.1146/annurev.immunol.22.012703.104622, 15032600.
55. Rossi DL, Vicari AP, Franz-Bacon K, McClanahan TK, Zlotnik A. Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3alpha and MIP-3beta. J Immunol 1997, 158:1033-1036.
56. Terao S, Yilmaz G, Stokes KY, Russell J, Ishikawa M, Kawase T, Granger DN. Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia-reperfusion. Stroke 2008, 39:2560-2570. 10.1161/STROKEAHA.107.513150, 2748665, 18635850.
57. Ikenaka Y, Yoshiji H, Kuriyama S, Yoshii J, Noguchi R, Tsujinoue H, Yanase K, Namisaki T, Imazu H, Masaki T, Fukui H. Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibits tumor growth and angiogenesis in the TIMP-1 transgenic mouse model. Int J Cancer 2003, 105:340-346. 10.1002/ijc.11094, 12704667.
58. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011, 473:298-307. 10.1038/nature10144, 21593862.
59. Argaw AT, Asp L, Zhang J, Navrazhina K, Pham T, Mariani JN, Mahase S, Dutta DJ, Seto J, Kramer EG. Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. J Clin Invest 2012, 122:2454-2468. 10.1172/JCI60842, 3386814, 22653056.
60. Marcon J, Gagliardi B, Balosso S, Maroso M, Noe F, Morin M, Lerner-Natoli M, Vezzani A, Ravizza T. Age-dependent vascular changes induced by status epilepticus in rat forebrain: implications for epileptogenesis. Neurobiol Dis 2009, 34:121-132. 10.1016/j.nbd.2008.12.018, 19320047.
61. Nikitidou L, Kanter-Schlifke I, Dhondt J, Carmeliet P, Lambrechts D, Kokaia M. VEGF receptor-2 (flk-1) overexpression in mice counteracts focal epileptic seizures. PLoS One 2012, 7:e40535. 10.1371/journal.pone.0040535, 3395684, 22808185.
62. Nag S, Papneja T, Venugopalan R, Stewart DJ. Increased angiopoietin2 expression is associated with endothelial apoptosis and blood-brain barrier breakdown. Lab Invest 2005, 85:1189-1198. 10.1038/labinvest.3700325, 16056241.
63. Shen F, Walker EJ, Jiang L, Degos V, Li J, Sun B, Heriyanto F, Young WL, Su H. Coexpression of angiopoietin-1 with VEGF increases the structural integrity of the blood-brain barrier and reduces atrophy volume. J Cereb Blood Flow 2011, 31:2343-2351.
64. Yu H, Wang P, An P, Xue Y. Recombinant human angiopoietin-1 ameliorates the expressions of ZO-1, occludin, VE-cadherin, and PKCalpha signaling after focal cerebral ischemia/reperfusion in rats. J Mol Neurosci 2012, 46:236-247. 10.1007/s12031-011-9584-5, 21710361.
65. Zhu Y, Lee C, Shen F, Du R, Young WL, Yang GY. Angiopoietin-2 facilitates vascular endothelial growth factor-induced angiogenesis in the mature mouse brain. Stroke 2005, 36:1533-1537. 10.1161/01.STR.0000170712.46106.2e, 15947259.
66. Pena F. Organotypic cultures as tool to test long-term effects of chemicals on the nervous system. Curr Med Chem 2010, 17:987-1001. 10.2174/092986710790820679, 20156165.
67. Sundstrom L, Morrison B, Bradley M, Pringle A. Organotypic cultures as tools for functional screening in the CNS. Drug Discov Today 2005, 10:993-1000. 10.1016/S1359-6446(05)03502-6, 16023058.
68. Kovacs R, Papageorgiou I, Heinemann U. Slice cultures as a model to study neurovascular coupling and blood brain barrier in vitro. Cardiovasc Psychiatry Neurol 2011, 2011:646958. 3042620, 21350722.
69. Mertsch K, Hanisch UK, Kettenmann H, Schnitzer J. Characterization of microglial cells and their response to stimulation in an organotypic retinal culture system. J Comp Neurol 2001, 431:217-227. 10.1002/1096-9861(20010305)431:2<217::AID-CNE1066>3.0.CO;2-T, 11170001.
70. Biron KE, Dickstein DL, Gopaul R, Jefferies WA. Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease. PLoS One 2011, 6:e23789. 10.1371/journal.pone.0023789, 3166122, 21909359.
71. Jiao H, Wang Z, Liu Y, Wang P, Xue Y. Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult. J Mol Neurosci: MN 2011, 44:130-139. 10.1007/s12031-011-9496-4, 21318404.
72. Marchi N, Guiso G, Caccia S, Rizzi M, Gagliardi B, Noe F, Ravizza T, Bassanini S, Chimenti S, Battaglia G, Vezzani A. Determinants of drug brain uptake in a rat model of seizure-associated malformations of cortical development. Neurobiol Dis 2006, 24:429-442. 10.1016/j.nbd.2006.07.019, 17027274.
73. van Vliet EA, da Costa AS, Redeker S, van Schaik R, Aronica E, Gorter JA. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 2007, 130:521-534. 10.1093/brain/awl318, 17124188.
74. Zlokovic BV. Neurodegeneration and the neurovascular unit. Nat Med 2010, 16:1370-1371. 10.1038/nm1210-1370, 21135839.
75. Boveri M, Berezowski V, Price A, Slupek S, Lenfant AM, Benaud C, Hartung T, Cecchelli R, Prieto P, Dehouck MP. Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line. Glia 2005, 51:187-198. 10.1002/glia.20189, 15800928.
76. Duport S, Stoppini L, Correges P. Electrophysiological approach of the antiepileptic effect of dexamethasone on hippocampal slice culture using a multirecording system: the Physiocard. Life Sci 1997, 60:PL 251-256.
77. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 2011, 12:723-738.